02/01/23 9:20 AMAMEX : RMED low floatRa Medical Systems Adds Additional Clinical and Sales RepresentativesRa Medical Systems, Inc. (NYSE American:RMED) (Ra Medical), a medical device and technology company focused on cardiac electrophysiology, announces that additionalRHEA-AIneutral
01/23/23 6:50 AMAMEX : RMED clinical triallow floatRa Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association CongressRa Medical Systems, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that four abstracts with clinical data supporting its VIVO technology have been accepted for presentation at the European Heart Rhythm Association Congress being held April 16-18, 2023 in Barcelona. VIVO, developed by Ra Medical’ s wholly...RHEA-AIneutral
01/09/23 7:30 PMAMEX, NYSE : RMED, MDT, ABT acquisitionlow floatRa Medical Systems Completes Merger with Catheter PrecisionRa Medical Systems, Inc. announces the completion of its previously announced stock-for-stock merger transaction with Catheter Precision, Inc., a company focused on the cardiac electrophysiology market. Mr. Jenkins was instrumental in operating several medical device startups, including Transneuronix, Inc., which was...RHEA-AIneutral
12/14/22 4:33 PMAMEX : RMED low floatRa Medical Systems Regains Compliance with NYSE American Continued Listing StandardsRa Medical Systems, Inc. announces that it has received notification from the NYSE American LLC that the Company has regained compliance with the NYSE American’ s continued listing standard. Ra Medical Systems, Inc. is a medical device company that owns intellectual property related to an advanced excimer laser-based platform for use in the treatment of...RHEA-AIneutral
12/01/22 6:50 AMAMEX : RMED low floatCatheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European HospitalsOn September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems, which, if completed, will result in a combined publicly traded company focusing on the cardiac electrophysiology market. VIVO has received marketing clearance from the U.S. FDA and has been awarded the CE mark. Under the terms of the...RHEA-AIpositive
11/29/22 6:50 AMAMEX : RMED low floatCatheter Precision’s VIVO™ Systems Used in More Than 20 Procedures at NYU Langone HospitalOn September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems, which, if completed, will result in a combined publicly traded company focusing on the cardiac electrophysiology market. “Completing the first 20 cases with VIVO at NYU Langone hospital is another milestone demonstrating clinical...RHEA-AIpositive
11/14/22 5:42 PMAMEX, NYSE : RMED, MDT earningslow floatRa Medical Systems Reports Third Quarter 2022 Financial ResultsRa Medical Systems, Inc. reports financial results for the three and nine months ended September 30, 2022 and provides a business update. On September 9, 2022, Ra Medical entered into an Agreement and Plan of Merger with privately held Catheter Precision, a medical device and technology company focused on cardiac electrophysiology. Under the terms of the...RHEA-AIpositive
10/20/22 4:05 PMAMEX : RMED low floatCatheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation ProceduresCatheter Precision, Inc., a medical device company focused on cardiac electrophysiology, announces receipt of three commercial orders in the past 60 days as usage of the device continues to increase in the U.S. On September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra Medical Systems,...RHEA-AIvery positive
10/17/22 4:05 PMAMEX : RMED low floatRa Medical Systems Raises $7.6 Million Through Completed At-The-Market FacilityRa Medical Systems, Inc. announces the completion of its at-the-market facility, raising gross proceeds of $7.6 million. “Proceeds from this offering help us meet the conditions of the proposed merger with Catheter Precision, and are another step toward bringing our shareholders the value of their groundbreaking electrophysiology technology to improve...RHEA-AIvery positive
10/04/22 8:00 AMAMEX : RMED low floatCatheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ TechnologyCatheter Precision, Inc., a medical device company focused on cardiac electrophysiology, announces the filing of a new U.S. patent application for its VIVO™ technology, as it continues its focus on patent protection for VIVO. On September 12, 2022 privately held Catheter Precision announced a definitive merger agreement with Ra...RHEA-AIpositive